Indomethacin for refractory COVID or post-COVID headache: a retrospective study.

Abouch V KrymchantowskiRaimundo Pereira da Silva-NétoCarla JevouxAna Gabriela Krymchantowski

Published in: Acta neurologica Belgica (2021)

In patients with migraine or no prior history of headache who present with refractory COVID or post-COVID headache to common analgesics, anti-inflammatory drugs, and/or triptans, indomethacin should be considered a therapeutic option.

Keyphrases

coronavirus disease
sars cov
anti inflammatory drugs
respiratory syndrome coronavirus